Global Trends in Research of Programmed Cell Death in Osteoporosis: A Bibliometric and Visualized Analysis (2000–2023)

Abstract

Osteoporosis (OP) is a systemic metabolic bone disease that is characterized by decreased bone mineral density and microstructural damage to bone tissue. Recent studies have demonstrated significant advances in the research of programmed cell death (PCD) in OP. However, there is no bibliometric analysis in this research field. This study searched the Web of Science Core Collection (WoSCC) database for literature related to OP and PCD from 2000 to 2023. This study used VOSviewers 1.6.20, the “bibliometrix” R package, and CiteSpace (6.2.R3) for bibliometric and visualization analysis. A total of 2905 articles from 80 countries were included, with China and the United States leading the way. The number of publications related to PCD in OP is increasing year by year. The main research institutions are Shanghai Jiao Tong University, Chinese Medical University, Southern Medical University, Zhejiang University, and Soochow University. Bone is the most popular journal in the field of PCD in OP, and the Journal of Bone and Mineral Research is the most co-cited journal. These publications come from 14,801 authors, with Liu Zong-Ping, Yang Lei, Manolagas Stavros C, Zhang Wei, and Zhao Hong-Yan having published the most papers. Ronald S. Weinstein was co-cited most often. Oxidative stress and autophagy are the current research hot spots for PCD in OP. This bibliometric study provides the first comprehensive summary of trends and developments in PCD research in OP. This information identifies the most recent research frontiers and hot directions, which will provide a definitive reference for scholars studying PCD in OP.

Keywords

Autophagy / Bibliometrix / Osteoporosis / Oxidative Stress / Programmed Cell Death

References

[1] Adejuyigbe B, Kallini J, Chiou D, et al. Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci. 2023; 24(19): 18.

[2] Shen YY, Huang X, Wu JY, et al. The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019. Front Endocrinol. 2022; 13: 11.

[3] Clynes MA, Harvey NC, Curtis EM, et al. The epidemiology of osteoporosis. Br Med Bull. 2020; 133(1): 105–117.

[4] Rashki Kemmak A, Rezapour A, Jahangiri R, et al. Economic burden of osteoporosis in the world: a systematic review. Med J Islam Repub Iran. 2020; 34: 154.

[5] Sugiyama T, Kim YT, Oda H. Osteoporosis therapy: a novel insight from natural homeostatic system in the skeleton. Osteoporos Int. 2015; 26(2): 443–447.

[6] Liu C, Mao X, Meng L, et al. Stresses make microbe undergo programmed cell death: mechanisms and opportunities. Food Res Int. 2022; 157: 111273.

[7] Shan B, Pan H, Najafov A, et al. Necroptosis in development and diseases. Genes Dev. 2018; 32(5–6): 327–340.

[8] Li Z, Li D, Chen R, et al. Cell death regulation: a new way for natural products to treat osteoporosis. Pharmacol Res. 2023; 187: 106635.

[9] Lu JL, Yu CX, Song LJ. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discovery. 2023; 9(1): 449.

[10] Holze C, Michaudel C, Mackowiak C, et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat Immunol. 2018; 19(2): 130–140.

[11] Chu PL, Wang T, Zheng JL, et al. Global and current research trends of unilateral Biportal endoscopy/Biportal endoscopic spinal surgery in the treatment of lumbar degenerative diseases: a bibliometric and visualization study. Orthop Surg. 2022; 14(4): 635–643.

[12] Yin M, Xu C, Ma J, et al. A bibliometric analysis and visualization of current research trends in the treatment of cervical Spondylotic myelopathy. Global Spine J. 2021; 11(6): 988–998.

[13] Zhu W, Ding X, Zheng J, et al. A systematic review and bibliometric study of Bertolotti’s syndrome: clinical characteristics and global trends. Int J Surg. 2023; 109(10): 3159–3168.

[14] Yin M, Wang H, Sun Y, et al. Global trends of researches on lumbar spinal stenosis: a bibliometric and visualization study. Clin Spine Surg. 2022; 35(1): E259–E266.

[15] Li C, Ojeda-Thies C, Renz N, et al. The global state of clinical research and trends in periprosthetic joint infection: a bibliometric analysis. Int J Infect Dis. 2020; 96: 696–709.

[16] Zhu Z, Zhou Y, Li H, et al. Research trends and hotspots in prostate cancer associated exosome: a bibliometric analysis. Front Oncol. 2023; 13: 1270104.

[17] Chen R, Jiang Y, Lu L, et al. Bibliometric analysis of research trends in stem cell therapy for knee osteoarthritis over the period 2001-2021. Front Cell Dev Biol. 2022; 10: 996273.

[18] Ma D, Guan B, Song L, et al. A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med. 2021; 8: 734514.

[19] Huang R, Jin M, Liu Y, et al. Global trends in research of fibroblasts associated with rheumatoid diseases in the 21st century: a bibliometric analysis. Front Immunol. 2023; 14: 1098977.

[20] Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84(2): 523–538.

[21] Pan XL, Yan EJ, Cui M, et al. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J Informetr. 2018; 12(2): 481–493.

[22] Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005; 2005: 724–728.

[23] Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004; 101(1): 5303–5310.

[24] Aria M, Cuccurullo C. An R-tool for comprehensive science mapping analysis. J Informetr. 2017; 11(4): 959–975.

[25] Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998; 102(2): 274–282.

[26] Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003; 423(6937): 337–342.

[27] Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21(2): 115–137.

[28] O’brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004; 145(4): 1835–1841.

[29] Plotkin LI, Weinstein RS, Parfitt AM, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999; 104(10): 1363–1374.

[30] Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31(3): 266–300.

[31] Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011; 377(9773): 1276–1287.

[32] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001; 25(4): 402–408.

[33] Jilka RL, Weinstein RS, Bellido T, et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999; 104(4): 439–446.

[34] Nollet M, Santucci-Darmanin S, Breuil V, et al. Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy. 2014; 10(11): 1965–1977.

[35] Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289(5484): 1504–1508.

[36] Weinstein RS, Chen JR, Powers CC, et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest. 2002; 109(8): 1041–1048.

[37] Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93(2): 165–176.

[38] Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2): 309–319.

[39] Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the Asbmr histomorphometry nomenclature committee. J Bone Miner Res. 1987; 2(6): 595–610.

[40] Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005; 115(12): 3318–3325.

[41] Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995; 10(10): 1478–1487.

[42] Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011; 26(2): 229–238.

[43] Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282(37): 27285–27297.

[44] Canalis E, Mazziotti G, Giustina A, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007; 18(10): 1319–1328.

[45] Xiong J, Onal M, Jilka RL, et al. Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17(10): 1235–1241.

[46] Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 2013; 28(1): 2–17.

[47] Sato AY, Tu X, Mcandrews KA, et al. Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice. Bone. 2015; 73: 60–68.

[48] Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017; 14(2): 209–216.

[49] Ma Y, Qi M, An Y, et al. Autophagy controls mesenchymal stem cell properties and senescence during bone aging. Aging Cell. 2018; 17(1): e12709.

[50] Li H, Li D, Ma Z, et al. Defective autophagy in osteoblasts induces endoplasmic reticulum stress and causes remarkable bone loss. Autophagy. 2018; 14(10): 1726–1741.

[51] Qi M, Zhang L, Ma Y, et al. Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent estrogen deficiency-induced osteoporosis. Theranostics. 2017; 7(18): 4498–4516.

[52] Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017; 4(1): 46–56.

[53] Shen G, Ren H, Shang Q, et al. Autophagy as a target for glucocorticoid-induced osteoporosis therapy. Cell Mol Life Sci. 2018; 75(15): 2683–2693.

[54] Lin NY, Chen CW, Kagwiria R, et al. Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss. Ann Rheum Dis. 2016; 75(6): 1203–1210.

[55] Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017; 5(11): 898–907.

[56] Black DM, Rosen CJ. Postmenopausal Osteoporosis. New Engl J Med. 2016; 374(3): 254–262.

[57] Compston JE, Mcclung MR, Leslie WD. Osteoporosis. Lancet. 2019; 393(10169): 364–376.

[58] Chen X, Wang Z, Duan N, et al. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018; 59(2): 99–107.

[59] Yin X, Zhou C, Li J, et al. Autophagy in bone homeostasis and the onset of osteoporosis. Bone Res. 2019; 7: 28.

[60] Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci. 2019; 20(14): 3576.

[61] Li X, Xu J, Dai B, et al. Targeting autophagy in osteoporosis: from pathophysiology to potential therapy. Ageing Res Rev. 2020; 62: 101098.

[62] Yin MC, Wang HS, Yang X, et al. A bibliometric analysis and visualization of current research trends in Chinese medicine for osteosarcoma. Chin J Integr Med. 2022; 28(5): 445–452.

[63] Almeida M, Han L, Ambrogini E, et al. Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem. 2011; 286(52): 44326–44335.

[64] Wang T, Liu X, He C. Glucocorticoid-induced autophagy and apoptosis in bone. Apoptosis. 2020; 25(3-4): 157–168.

[65] Hua R, Zhang J, Riquelme MA, et al. Connexin gap junctions and hemichannels link oxidative stress to skeletal physiology and pathology. Curr Osteoporos Rep. 2021; 19(1): 66–74.

[66] Chen M, Fu W, Xu H, et al. Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine Growth Factor Rev. 2023; 70: 54–66.

[67] Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell Dev Biol. 2022; 123: 14–21.

[68] Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114(12): 1752–1761.

[69] Zhu C, Shen S, Zhang S, et al. Autophagy in bone remodeling: a regulator of oxidative stress. Front Endocrinol. 2022; 13: 898634.

[70] Chaudhary P, Janmeda P, Docea AO, et al. Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. Front Chem. 2023; 11: 1158198.

[71] Zhang C, Li H, Li J, et al. Oxidative stress: a common pathological state in a high-risk population for osteoporosis. Biomed Pharmacother. 2023; 163: 114834.

[72] Wang N, Hao Y, Fu L. Trimethylamine-N-oxide promotes osteoclast differentiation and bone loss via activating ROS-dependent NF-kappaB signaling pathway. Nutrients. 2022; 14(19): 3955.

[73] Kim WK, Ke K, Sul OJ, et al. Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. J Cell Biochem. 2011; 112(11): 3159–3166.

[74] Monteiro C, Ferreira De Oliveira JMP, Pinho F, et al. Biochemical and transcriptional analyses of cadmium-induced mitochondrial dysfunction and oxidative stress in human osteoblasts. J Toxicol Environ Health, Part A. 2018; 81(15): 705–717.

[75] Hu X, Li B, Wu F, et al. Gpx7 facilitates BMSCs Osteoblastogenesis via ER stress and mTOR pathway. J Cell Mol Med. 2021; 25(22): 10454–10465.

[76] Du J, Feng W, Sun J, et al. Ovariectomy upregulated the expression of peroxiredoxin 1 &5 in osteoblasts of mice. Sci Rep. 2016; 6: 35995.

[77] Gong W, Liu M, Zhang Q, et al. Orcinol glucoside improves senile osteoporosis through attenuating oxidative stress and autophagy of osteoclast via activating Nrf2/Keap1 and mTOR signaling pathway. Oxid Med Cell Longev. 2022; 2022: 5410377.

[78] Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018; 19(6): 349–364.

[79] Xilouri M, Stefanis L. Chaperone mediated autophagy in aging: starve to prosper. Ageing Res Rev. 2016; 32: 13–21.

[80] Schuck S. Microautophagy—distinct molecular mechanisms handle cargoes of many sizes. J Cell Sci. 2020; 133(17): jcs246322.

[81] Feng Y, He D, Yao Z, et al. The machinery of macroautophagy. Cell Res. 2014; 24(1): 24–41.

[82] Li DY, Yu JC, Xiao L, et al. Autophagy attenuates the oxidative stress-induced apoptosis of Mc3T3-E1 osteoblasts. Eur Rev Med Pharmacol Sci. 2017; 21(24): 5548–5556.

[83] Arai A, Kim S, Goldshteyn V, et al. Beclin1 modulates bone homeostasis by regulating osteoclast and chondrocyte differentiation. J Bone Miner Res. 2019; 34(9): 1753–1766.

[84] Nichols JJ, Jones LW, Morgan PB, et al. Bibliometric analysis of the meibomian gland literature. Ocul Surf. 2021; 20: 212–214.

RIGHTS & PERMISSIONS

2024 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.